Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10776584 [patent_doc_number] => 20160122740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND METHOD FOR ITS PRODUCTION' [patent_app_type] => utility [patent_app_number] => 14/981981 [patent_app_country] => US [patent_app_date] => 2015-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12324 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14981981 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/981981
FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND METHOD FOR ITS PRODUCTION Dec 28, 2015 Abandoned
Array ( [id] => 16414510 [patent_doc_number] => 10822386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Insulin analogues with enhanced stability and reduced mitogenicity [patent_app_type] => utility [patent_app_number] => 15/539450 [patent_app_country] => US [patent_app_date] => 2015-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9623 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539450 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/539450
Insulin analogues with enhanced stability and reduced mitogenicity Dec 23, 2015 Issued
Array ( [id] => 11798088 [patent_doc_number] => 09538779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Tube feed formulations and methods for using same' [patent_app_type] => utility [patent_app_number] => 14/966800 [patent_app_country] => US [patent_app_date] => 2015-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18674 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14966800 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/966800
Tube feed formulations and methods for using same Dec 10, 2015 Issued
Array ( [id] => 11025109 [patent_doc_number] => 20160222064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/960206 [patent_app_country] => US [patent_app_date] => 2015-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 22026 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14960206 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/960206
HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE Dec 3, 2015 Abandoned
Array ( [id] => 15054845 [patent_doc_number] => 10457711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Dermatophagoides farinae protein [patent_app_type] => utility [patent_app_number] => 15/532256 [patent_app_country] => US [patent_app_date] => 2015-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7006 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532256 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/532256
Dermatophagoides farinae protein Nov 30, 2015 Issued
Array ( [id] => 13237001 [patent_doc_number] => 10131691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-20 [patent_title] => Compositions and methods for specific regulation of pyruvate dehydrogenase kinase [patent_app_type] => utility [patent_app_number] => 14/943735 [patent_app_country] => US [patent_app_date] => 2015-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 31 [patent_no_of_words] => 12237 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14943735 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/943735
Compositions and methods for specific regulation of pyruvate dehydrogenase kinase Nov 16, 2015 Issued
Array ( [id] => 10767920 [patent_doc_number] => 20160114075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'PHOTOACTIVATED CROSSLINKING OF A PROTEIN OR PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/941814 [patent_app_country] => US [patent_app_date] => 2015-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16915 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14941814 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/941814
Photoactivated crosslinking of a protein or peptide Nov 15, 2015 Issued
Array ( [id] => 12137053 [patent_doc_number] => 20180015136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'THERAPEUTIC HOMODIMER AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/527904 [patent_app_country] => US [patent_app_date] => 2015-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14439 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527904 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/527904
THERAPEUTIC HOMODIMER AND USES THEREOF Nov 15, 2015 Abandoned
Array ( [id] => 12000249 [patent_doc_number] => 20170304405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'TREATMENT OF HORMONAL DISORDERS OF GROWTH' [patent_app_type] => utility [patent_app_number] => 15/525928 [patent_app_country] => US [patent_app_date] => 2015-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27294 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525928 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/525928
Treatment of hormonal disorders of growth Nov 11, 2015 Issued
Array ( [id] => 12657004 [patent_doc_number] => 20180110834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => METHODS FOR TREATMENT OF BILE ACID-RELATED DISORDERS AND PREDICTION OF CLINICAL SENSITIVITY TO TREATMENT OF BILE ACID-RELATED DISORDERS [patent_app_type] => utility [patent_app_number] => 15/524896 [patent_app_country] => US [patent_app_date] => 2015-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524896 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/524896
Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders Nov 5, 2015 Issued
Array ( [id] => 10774625 [patent_doc_number] => 20160120781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'SKINCARE FORMULATIONS AND REGIMENS' [patent_app_type] => utility [patent_app_number] => 14/931744 [patent_app_country] => US [patent_app_date] => 2015-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8381 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14931744 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/931744
Skincare formulations and regimens Nov 2, 2015 Issued
Array ( [id] => 10770302 [patent_doc_number] => 20160116457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'TRANSMEMBRANE PROTEINS AS BIOSENSORS' [patent_app_type] => utility [patent_app_number] => 14/930395 [patent_app_country] => US [patent_app_date] => 2015-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 19792 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14930395 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/930395
TRANSMEMBRANE PROTEINS AS BIOSENSORS Nov 1, 2015 Abandoned
Array ( [id] => 14031643 [patent_doc_number] => 10227561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-12 [patent_title] => Methods and compositions for targeting progenitor cell lines [patent_app_type] => utility [patent_app_number] => 14/930505 [patent_app_country] => US [patent_app_date] => 2015-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 24289 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14930505 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/930505
Methods and compositions for targeting progenitor cell lines Nov 1, 2015 Issued
Array ( [id] => 10761978 [patent_doc_number] => 20160108132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'Antitumor Peptide Derived From A Complementarity Determining Region of a Humanized Monoclonal Antibody to NAP12B Transporter' [patent_app_type] => utility [patent_app_number] => 14/924003 [patent_app_country] => US [patent_app_date] => 2015-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 12480 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14924003 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/924003
Antitumor peptide derived from a complementarity determining region of a humanized monoclonal antibody to NAP12B transporter Oct 26, 2015 Issued
Array ( [id] => 13479661 [patent_doc_number] => 20180291373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => USE OF THERAPEUTIC AGENTS [patent_app_type] => utility [patent_app_number] => 15/522600 [patent_app_country] => US [patent_app_date] => 2015-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9937 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522600 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/522600
USE OF THERAPEUTIC AGENTS Oct 25, 2015 Abandoned
Array ( [id] => 10820490 [patent_doc_number] => 20160166654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'COLLAGEN-TARGETED NANOPARTICLES' [patent_app_type] => utility [patent_app_number] => 14/884646 [patent_app_country] => US [patent_app_date] => 2015-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11341 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14884646 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/884646
COLLAGEN-TARGETED NANOPARTICLES Oct 14, 2015 Abandoned
Array ( [id] => 11555228 [patent_doc_number] => 20170101474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => 'SYNTHETIC ANTIBODY MIMIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/882436 [patent_app_country] => US [patent_app_date] => 2015-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18795 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14882436 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/882436
Synthetic antibody mimic peptides Oct 12, 2015 Issued
Array ( [id] => 16892075 [patent_doc_number] => 11033602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Inhalation device [patent_app_type] => utility [patent_app_number] => 15/516286 [patent_app_country] => US [patent_app_date] => 2015-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8743 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516286 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/516286
Inhalation device Sep 30, 2015 Issued
Array ( [id] => 10693796 [patent_doc_number] => 20160039943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'METHOD OF INCREASING PLASMIN ACTIVITY THROUGH ANTIPLASMIN CONVERSION' [patent_app_type] => utility [patent_app_number] => 14/872776 [patent_app_country] => US [patent_app_date] => 2015-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10539 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872776 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/872776
Method of increasing plasmin activity through antiplasmin conversion Sep 30, 2015 Issued
Array ( [id] => 11956085 [patent_doc_number] => 20170260236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'COMPOSITIONS FOR EXPANDING REGULATORY T CELLS (TREG), AND TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES AND CONDITIONS' [patent_app_type] => utility [patent_app_number] => 15/510667 [patent_app_country] => US [patent_app_date] => 2015-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21982 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510667 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/510667
Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions Sep 28, 2015 Issued
Menu